Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
Titel:
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
Auteur:
Conklin, Laurie S. Damsker, Jesse M. Hoffman, Eric P. Jusko, William J. Mavroudis, Panteleimon D. Schwartz, Benjamin D. Mengle-Gaw, Laurel J. Smith, Edward C. Mah, Jean K. Guglieri, Michela Nevo, Yoram Kuntz, Nancy McDonald, Craig M. Tulinius, Mar Ryan, Monique M. Webster, Richard Castro, Diana Finkel, Richard S. Smith, Andrea L. Morgenroth, Lauren P. Arrieta, Adrienne Shimony, Maya Jaros, Mark Shale, Phil McCall, John M. Hathout, Yetrib Nagaraju, Kanneboyina van den Anker, John Ward, Leanne M. Ahmet, Alexandra Cornish, Michaelyn R. Clemens, Paula R.